Samsung Biologics said Thursday the company won a $411.3 million contract manufacturing deal from Pfizer to produce the US-based pharmaceutical giant’s biosimilar products. Even though the company didn’t specify the product name, industry watchers predict that the deal is highly likely to involve producing Pfizer’s Abrilada, a biosimilar to the autoimmune disease drug known as Humira. In the st...

South Korea's biopharmaceutical company Celltrion announced Monday that the company will cooperate with the US biotech firm Rani Therapeutics to develop an oral version of the Humira biosimilar CT-P17. CT-P17, also known as Yuflyma, is a high-concentration, low-volume and citrate-free biosimilar of Humira, an injectable treatment for rheumatoid arthritis and other autoimmune conditions, develope...

South Korean drugmaker Daewoong Pharmaceutical said Monday that it is in talks with multinational pharmaceutical companies to carry out clinical trials of Fexuprazan, its new gastroesophageal reflux disease treatment, in key markets such as the US, Europe and Japan. The announcement comes after Daewoong ended its partnership with US biotech firm Neurogastrx on the same day. Earlier in June 2021...

Hanjin Group Chairman and Korean Air CEO Walter Cho received the Excellence in Leadership Award by Air Transport World, the company said Sunday. The award ceremony was held at the Grand Cevahir Hotel in Istanbul, Turkey, on Friday, Korean Air said. The award was established in 1974 by ATW, a publication covering global air transportation, and is one of the most prominent awards in the industry,...

Posco has launched the country’s first low-carbon steel product in line with the steelmaker’s ambitious goal to achieve carbon neutrality by 2050, the company said Sunday. LG Electronics has become the first client to purchase the newly-launched low-emission steel product for the company’s home appliances production, the company added. Posco’s new steel product, named Greenate certified steel, ...

Posco Group Chairman Choi Jeong-woo said the group is paying extra attention to the inflation-triggered financial market volatility and the growing geopolitical risks. Choi added the group will overcome the difficulties by making aggressive investments in battery materials businesses, particularly those relating to the electric vehicle industry, during an interview organized by the Korea Society...

Daewoo Engineering & Construction's Chairman Jung Won-ju, who doubles as vice chairman of Jungheung Group, met with Turkmenistan's president and other top officials to discuss new business projects in the Central Asian country, the South Korean builder said Wednesday. According to the company, Jung met with Turkmenistan’s de facto leader Gurbanguly Berdymukhamedov, the former president who curre...

SK Bioscience announced on Tuesday that its COVID-19 vaccine SKYCovione received approval from the UK Medicines and Healthcare products Regulatory Agency. SKYCovione has been approved for first and second primary series doses for adults aged 18 and over in England, Scotland and Wales, SK Bioscience added. SKYCovione is a recombinant antigen-based COVID-19 vaccine, jointly developed with the Ins...

Finding a pediatric clinic in South Korea has become increasingly difficult due to a continuing shortage of pediatricians, leading to longer wait times for patients to get treated. “It is very common to wait for dozens of people who made reservations before you,” Yoo, a mother of a 4-year-old boy, told The Korea Herald. Yoo, 35, who is living in Gyeonggi Province, said her child had a fever las...

Daewoo Engineering & Construction announced Friday that Jungheung Group Vice Chairman Jung Won-ju will become chairperson of the company, starting June 1. Jungheung Group is the largest shareholder of Daewoo E&C with a controlling 50.75 percent stake after completing the acquisition process last year. Daewoo E&C said the latest change in its leadership has been made to boost its business in ove...

Celltrion said Friday that the company has submitted a marketing authorization application for CT-P43, the company's ustekinumab biosimilar referencing Stelara, to the European Medicines Agency. Stelara is one of Janssen's top-selling drugs. In 2022, Stelara generated $9.7 billion in revenue, according to a report released by Statista. The global market for ustekinumab last year was estimated a...

South Korean steel giant Posco said Thursday that the company completed a new high-strength steel plant in China in a preemptive measure to respond to soaring demand from the burgeoning Chinese electric vehicle market. The new facility, located at Posco-CSPC (China Suzhou Processing Center), is a plant specialized in producing “Giga Steel,” the brand name for Posco’s advanced ultra-high tensile ...

Celltrion's adalimumab biosimilar CT-P17 has been approved the US Food and Drug Administration, the company announced Wednesday. CT-P17, also known as Yuflyma, is the world’s first high-concentration, low-volume and citrate-free biosimilar of Humira, an injectable treatment for rheumatoid arthritis and other autoimmune conditions. Celltrion said CT-P17 had been approved as a treatment for multi...

Demand for cold medicines has increased recently, as the seasonal flu has continued longer than usual. With the spurt in cold and flu cases, sales of cold medicines have increased while some pharmacies face shortages, according to data from the government and local pharmaceutical companies on Tuesday. “Demand for over-the-counter cold medicines seems to be higher than usual, and some prescriptio...

The nation’s largest discount store chain E-mart, owned by retail giant Shinsegae Group, suffered dismal sales in the first quarter this year, outpaced by its smaller rival Coupang for the first time, with a gloomy outlook for the rest of the year, according to local brokerage firms Monday. In the first three months of the year, E-mart posted 13.7 billion won ($10.3 million) in operating profits...